Hematologic Neoplasms: Clinical Trials

3 trials for Hematologic Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Terminated 3

Follow Hematologic Neoplasms: new trials by email Literature Review of Hematologic Neoplasms trials Research Report on Hematologic Neoplasms

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of HU-resistance in Adult Patients With Polycythemia Vera Who Meet PV-AIM Predictors
Hydroxyurea - Polycythemia Vera
Phase 4TerminatedNovartis Pharmaceuticals762023-07-282026-08-18
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation
Ceftolozane / Tazobactam Injection - Pneumonia, Hematologic Malignancy
Phase 4TerminatedWeill Medical College of Cornell University172023-01-102026-01-21
A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy
Itraconazole, Caspofungin - Hematologic Neoplasms
Phase 4TerminatedXian-Janssen Pharmaceutical Ltd.612016-11-302019-05-06

Narrower conditions

Bacteremia (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Pneumonia (1)  ·  Polycythemia Vera (1)  ·  Pseudomonas Infections (1)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Bone Marrow Diseases (1)  ·  Bone Marrow Neoplasms (1)  ·  Infections (1)  ·  Inflammation (1)  ·  Lung Diseases (1)  ·  Myeloproliferative Disorders (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Caspofungin (1)  ·  Hydroxyurea (1)  ·  Itraconazole (1)  ·  ceftolozane, tazobactam drug combination (1)

Sponsors

Novartis Pharmaceuticals (1)  ·  Weill Medical College of Cornell University (1)  ·  Xian-Janssen Pharmaceutical Ltd. (1)

Countries

China (1)  ·  Germany (1)  ·  United States (1)

Top investigators

Markus Plate, MD (1)